Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
have to adjust recuriting paticipants projects and have to halted the research
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Firestone Institute for Respiratory Health | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to establish the methodology of bronchial dilation test by salbutamol MDI with Spacer in wheezy infants with asthma and to evaluate the effects of atopy on the exacerbation of wheeze in wheezy infants.
After screening,each participant undergo baseline pulmonary function test(Jaeger Master Screen Baby Body, Germany)and post-bronchodilator measurements that performed 10min after 200ug of salbutamol administered using a metered-dose inhaler and a spacer.
The participants undergo baseline lung function test and bronchial dilation tests on the second and third visits with one-month interval,and whenever there is an exacerbation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| healthy | healthy control, 5 months to 3 years | ||
| wheezing with atopy | suspected asthma with wheezing (>3 episodes per year) and atopy | ||
| wheezing without atopy | wheezing without atopy |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| airway resistance(Raw) performed by body plethysmography before and after bronchial dilation test. | airway resistance(Raw) at rest | Change from baseline at 20 mins after inhalation of salbutamol |
| Measure | Description | Time Frame |
|---|---|---|
| airway resistance(Raw) performed by body plethysmography | airway resistance(Raw) measured within 24 hours whenever there is an exacerbation of wheeze. | at 24 hours of the exacerbation of wheeze |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
all the subjects will be recurited from the First Affiliated Hospital of Guangzhou Medical University
Not provided
| Name | Affiliation | Role |
|---|---|---|
| jinping Zheng | Guangzhou Institute of Respiratory Disease | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| State Key Laboratory of Respiratory Disease;China Clinical Research Center of Respiratory Disease;First Affiliated Hospital of Guangzhou Medical University | Guangzhou | Guangdong | 510120 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |